1. An innovative hybrid mathematical hierarchical regression model for breast cancer diseases analysis
   B. Monica Jenefer et al, 2018, Cluster Comput CrossRef
2. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro
   Liu Yang et al, 2018, Breast Cancer Res CrossRef
3. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein
   Wen-ting He et al, 2018, Chin. J. Integr. Med. CrossRef
4. A Review of Complementary Therapies with Medicinal Plants for Chemotherapy-induced Peripheral Neuropathy
   Bei-Yu Wu et al, 2018, Complementary Therapies in Medicine CrossRef
5. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
   Sita Sharan Patel et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
6. Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer
   Xue Wang et al, 2019, Thorac Cancer CrossRef
7. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis
   Hualong Zhang et al, 2019, Life Sciences CrossRef
8. The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment
   Yubo Zhang et al, 2019, Phytochem Rev CrossRef
9. An LC-MS/MS Method for Synchronous Determination of Paclitaxel and Curcumin: Development, Validation, and Application to a Pharmacokinetic Study
   Kaifeng Qiu et al, 2019, CPA CrossRef
10. Investigating the effect of radiosensitizer for Ursolic Acid and Kamolonol Acetate ‌ on HCT-116 cell line
    Maede Hasan Abdali et al, 2019, Bioorganic & Medicinal Chemistry CrossRef
11. The Cytoprotective and Anti-cancer Potential of Bisbenzylisoquinoline Alkaloids from Nelumbo nucifera
    Prasath Manogaran et al, 2020, CTMC CrossRef
12. Combination treatment of bicalutamide and curcumin has a strong therapeutic effect on androgen receptor-positive triple-negative breast cancers
    Shengli Dong et al, 2020, Anti-Cancer Drugs CrossRef
13. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
    Tatul Saghatelyan et al, 2020, Phytomedicine CrossRef
14. Lower concentrations of curcumin inhibit Her2-Akt pathway components in human breast cancer cells, and other dietary botanicals potentiate this and lapatinib inhibition
    Abhinav R Saxena et al, 2020, Nutrition Research CrossRef
15. Intraductal Therapy in Breast Cancer: Current Status and Future Prospective
    Xin-Wen Kuang et al, 2020, J Mammary Gland Biol Neoplasia CrossRef
16. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
    Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef
17. Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells
    Jie Li et al, 2019, Mol Med Report CrossRef
18. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells
    Xiaoli Ren et al, 2018, Mol Med Report CrossRef
19. Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells
    Shan Hu et al, 2018, Exp Ther Med CrossRef
20. Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action.
    Donovan A McGrowder et al, 2020, Medicines (Basel) CrossRef
21. Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells
    Ajda Coker-Gurkan et al, 2020, Mol Biol Rep CrossRef
22. Mining pharmacotherapy utility from chemodiversity/biodiversity of Taxus plants
    Da-Cheng Hao, 2021 CrossRef
23. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway
    Shu-rong Zheng et al, 2021 CrossRef
24. Genetic, biochemical and histopathological evaluations of thymoquinone on male reproduction system damaged by paclitaxel in Wistar rats
    Shima Moradi Maryamneghari et al, 2021, Andrologia CrossRef
25. New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
    Keyvan Khazei et al, 2021, CCDT CrossRef
26. Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
    Khor Poh Yen et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
27. Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies
    Satish Kumar Vemuri et al, 2022, IJMS CrossRef
28. Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer
    Reyhaneh Farghadani et al, 2022, IJMS CrossRef
29. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
    Sajad Fakhri et al, 2022, Front. Oncol. CrossRef
30. The antiproliferative and apoptotic potential of Clinacanthus nutans against human breast cancer cells through targeted apoptosis pathway
    Noor Zafirah Ismail et al, 2022, Environ Sci Pollut Res CrossRef
31. Chemopreventive Role of Phytoconstituents in Breast Cancer: An Integration Therapy
    Priya Bhatt et al, 2022, CBC CrossRef
32. Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
    Chao Pi et al, 2022, Drug Delivery CrossRef
33. Curcumin Modulates Oxidative Stress, Fibrosis, and Apoptosis in Drug-Resistant Cancer Cell Lines
    Sami A. Gabr et al, 2022, Life CrossRef
34. Future Perspectives of Phytochemicals in Cancer Therapy
    Bakiye Goker Bagca et al, 2022 CrossRef
35. Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
    Sena Karaosmanoglu et al, 2022, Bioengineering CrossRef
36. Fabrication, Optimization, and Evaluation of Paclitaxel and Curcumin Coloaded PLGA Nanoparticles for Improved Antitumor Activity
    Haiyang Hu et al, 2022, ACS Omega CrossRef
37. 4-methylthiobutyl isothiocyanate synergize the antiproliferative and pro-apoptotic effects of paclitaxel in human breast cancer cells
    Harneetpal Kaur et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
38. Anti-leukemic effect of menthol, a peppermint compound, on induction of apoptosis and autophagy
    Mashima Naksawat et al, 2023 CrossRef
39. Liposome bilayer stability: emphasis on cholesterol and its alternatives
    Hamdi Nsairat et al, 2023, Journal of Liposome Research CrossRef
40. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
    Yan Chang et al, 2024, Chem Biol Drug Des CrossRef
41. Paclitaxel for breast cancer therapy: A review on effective drug combination modalities and nano drug delivery platforms
    Masoumeh Kaveh Zenjanab et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
42. Suppression of B7-H7 Enhanced MCF-7 Cancer Cell Line’s Chemosensitivity to Paclitaxel
    Bita Amir Taghavi et al, 2024, Mol Biotechnol CrossRef
43. Antibacterial and Anti-cancer Properties of Curcumin-Functionalized Silica-Coated Fe3O4 Magnetic Nanoparticles
    Sahar Pourasgar et al, 2024, Arab J Sci Eng CrossRef
44. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
    Reyhaneh Farghadani et al, 2021, Cancers CrossRef
45. Is Curcumin the Answer to Future Chemotherapy Cocktail?
    Wei-Yang Kong et al, 2021, Molecules CrossRef
46. Cyclodextrin nanocarriers in Coordination Chemistry: Enhancing encapsulation and targeted delivery of 5-Fluorouracil for cancer treatment
    Sara Payamifar et al, 2024, Results in Chemistry CrossRef
47. Phytochemicals as Novel Therapeutics for Triple‐Negative Breast Cancer: A Comprehensive Review of Current Knowledge
    Zeeshan Ahmad Bhutta et al, 2024, Phytotherapy Research CrossRef
48. Recent progress on small molecule TLR4 antagonist against triple-negative breast cancer progression and complications
    Darsshen Ramana A.L. Kathirasan et al, 2024, Bioorganic & Medicinal Chemistry CrossRef